Plegia, or paralysis, is a paralysis of skeletal muscles. An incomplete paralysis is also known as a paresis. A plegia is generally caused by damage to one or more nerves that travel from the brain to the muscle and initiate movements.
Paralysis (Plegia) Treatment Market: Introduction
- Plegia, or paralysis, is a paralysis of skeletal muscles. An incomplete paralysis is also known as a paresis. A plegia is generally caused by damage to one or more nerves that travel from the brain to the muscle and initiate movements. Nerves could disrupt along their course in the upper or lower motor neuron, i.e. in the spinal cord, in the brain, or in the body. Plegia could be classified by the location of damage or by the affected limb.
- Depending on the location of nerve disruption, either in the lower or upper motor neuron, plegia is classified as central or peripheral. The lower motor neuron expands from the anterior horn cell of the spinal cord to the neuromuscular junction of the muscle. An injury in the lower motor neuron is also known as a peripheral plegia. Peripheral plegia usually affects one or more nerves (plexus paresis). The upper motor neuron usually runs from the brain to the anterior horn cell of the spinal cord. If damage occurs in the upper motor neuron of the nerve, it is known as central plegia. Paralyses are diagnosed by testing the muscle strength. The clinical diagnosis of muscle strength is carried out by assessments. The most common is the diagnosis with the help of the Medical Research Council (MRC), where 0 points represent a paralysis, i.e. plegia.
- The paralysis (plegia) treatment market can be segmented based on type, end-user, and region. Based on type, the market can be categorized into physical therapy, occupational therapy, and assistive devices & medications. Meanwhile, the assistive devices segment can be further classified into walkers, wheelchairs, grab bars, specialized handles, and grips & voice-activated technology. Based on end-user, the market can be split into hospitals, specialty clinics, ambulatory surgical centers, homecare, & others.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=81935
Key Drivers, Restraints, and Opportunities of Global Paralysis (Plegia) Treatment Market
- The shortage of physical activity and the adoption of an unhealthy lifestyle, collaborations & acquisitions by pharmaceuticals companies for the technological advancement of treatment are major factors driving the paralysis (plegia) treatment market
- However, limited availability of treatment options owing to the lower prevalence of (plegia) paralysis and fewer approvals of drugs from regulatory authorities is estimated to hamper the market during the during forecast period
- Increase in healthcare expenditure and substantial financial support to researchers for the development of novel interventions are projected to provide significant opportunity for the market
Request for Analysis of COVID-19 Impact on Paralysis (Plegia) Treatment Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=81935
North America to Capture Major Share of Global Paralysis (Plegia) Treatment Market
In terms of region, North America is anticipated to dominate the global market during the forecast period. North America followed by Europe is projected to hold a major share of the paralysis (plegia) treatment market. Rise in sleep disorders, increase in awareness, and surge in R&D activity for chronic disorders are key factors that are estimated to drive the market in the region. Emerging economies such as China and India are developing pharmaceutical products and are expected to contribute majorly toward the expansion of the paralysis (plegia) treatment market in Asia Pacific.
Pre book Paralysis (Plegia) Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=81935<ype=S
North America to Account for Major Share of Global Paralysis (Plegia) Treatment Market
- North America is projected to account for a major share of the global Paralysis (Plegia) Treatment market during the forecast period. The market in the region is anticipated to expand at a rapid pace in the next few years due to an increase in research & development and technologically advanced products being introduced in the market. Europe is expected to be the second-largest market during the forecast period owing to advanced facilities provided by the hospital infrastructure in the region.
- The Paralysis (Plegia) Treatment market in Asia Pacific is likely to expand at a high CAGR during the forecast period owing to the dense population and high birthrate in the region
Top of Form
Ask for Discount :
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=81935
Key Players Operating in Global Paralysis (Plegia) Treatment Market
The global paralysis (plegia) treatment market is highly fragmented, with the presence of various key players. A large number of manufacturers hold a major share in their respective regions. Major players operating in the global paralysis (plegia) treatment market are:
- Strongbridge Biopharma plc
- Sun Pharmaceutical Industries Ltd
- Heritage
- Mylan N.V.
- Zydus Cadila
- Alembic Pharmaceuticals Limited
- Teva Pharmaceutical Industries Ltd
- X-GEN Pharmaceuticals, Inc
- Cyberonics, Inc.
- Novartis AG
- Astellas Pharma Inc.
- Mallinckrodt
- Stryker
- Teleflex Incorporated
- Acclarent, Inc. (Johnson & Johnson)
- Medtronic
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453